DrugPatentWatch Database Preview
Drugs in Development Information for Palifosfamide
Development status for investigational drug Palifosfamide: Patents, clinical trial progress, indications
Palifosfamide is an investigational drug.
There have been 8 clinical trials for Palifosfamide.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Testicular Neoplasms, Sarcoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are Ziopharm, Indiana University School of Medicine, and [disabled in preview].
There are sixteen US patents protecting this investigational drug and one hundred and thirty-nine international patents.
Summary for Palifosfamide
| US Patents | 16 |
| International Patents | 139 |
| US Patent Applications | 22 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2012-05-01) |
| Vendors | 29 |
Recent Clinical Trials for Palifosfamide
| Title | Sponsor | Phase |
|---|---|---|
| Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer. | Ziopharm | Phase 2 |
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Ziopharm | Phase 2 |
| Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Indiana University School of Medicine | Phase 2 |
Clinical Trial Summary for Palifosfamide
Top disease conditions for Palifosfamide
Top clinical trial sponsors for Palifosfamide
US Patents for Palifosfamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Palifosfamide | See Pricing | Formulations and methods of reducing toxicity of antineoplastic agents | BioNumerik Pharmaceuticals, Inc. (San Antonio, TX) | See Pricing |
| Palifosfamide | See Pricing | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents | DEKK-TEC, Inc. (New Orleans, LA) | See Pricing |
| Palifosfamide | See Pricing | Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents | Ziopharm Oncology, Inc. (Boston, MA) | See Pricing |
| Palifosfamide | See Pricing | Phosphoramidate alkylator prodrugs | Threshold Pharmaceuticals, Inc. (Redwood CIty, CA) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Palifosfamide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Palifosfamide | Austria | 237337 | 2014-11-14 | See Pricing |
| Palifosfamide | Austria | 262329 | 2014-11-14 | See Pricing |
| Palifosfamide | Australia | 1090899 | 2014-11-14 | See Pricing |
| Palifosfamide | Australia | 4116896 | 2014-11-14 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
